Across TCGA pan-cancer cohorts, SLC25A51P4 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of SLC25A51P4’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where SLC25A51P4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SLC25A51P4 is over-expressed in tumor.
KIRC, HNSC, and LUAD are the cancer types where SLC25A51P4 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC25A51P4 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.